Upcoming Trials Screening

Type I Diabetes (Spring 2020)

Sponsor: Gan Lee
Primary Investigator: Dr. Wendell Miers

 

The study compares Insulin aspart to Novorapid in adults.

  • Must be 18-75 years of age
  • Must be a Type I Diabetic
  • Must have had treatment with an approved basal and bolus insulin regimen for the last 6 months (no changes in type or brand for 6 months)
  • HbA1c < 10.0%

If you are interested in learning more about a specific trial and possible participation, please complete the form for enrollment.